Actively Recruiting
Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2025-03-21
76
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
Sponsors
C
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor
U
Université du Québec à Trois-Rivières
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.
CONDITIONS
Official Title
Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 60 18 years of age with a diagnosis of head or neck cancer
- Chemoradiotherapy treatments planned for curative purposes
- Planned external radiation therapy dose of at least 60 60 Grays
- Sufficient proficiency in French to complete self-reported questionnaires
You will not qualify if you...
- Remote metastases
- Previous or planned total laryngectomy
- Previous moderate or severe dysphagia known and/or evaluated by speech therapy
- Diagnosis of a second synchronous cancer at the time of study enrollment
- History of prior radiation therapy to the head and neck area
- Cognitive impairment (diagnosed or suspected) that may interfere with participation and measurements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2x 3E4
Actively Recruiting
Research Team
M
Marie-Eve Caty, M.P.O., Ph.D.
CONTACT
H
Houda Bahig, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here